BIOMARIN PHARMACEUTICAL INC Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for March 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 76.30 | 1,181 | 90,110 | 61,439 | 62.6 K to 61.4 K (-1.89 %) |
| Mar 26 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 76.30 | 1,181 | 90,110 | 61,439 | 62.6 K to 61.4 K (-1.89 %) |
| Mar 23 2021 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | EVP, Chief Financia ... | Payment of Exercise | F | 78.52 | 516 | 40,516 | 36,708 | 37.2 K to 36.7 K (-1.39 %) |
| Mar 23 2021 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Payment of Exercise | F | 78.52 | 2,454 | 192,688 | 106,142 | 108.6 K to 106.1 K (-2.26 %) |
| Mar 23 2021 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Payment of Exercise | F | 78.52 | 1,391 | 109,221 | 68,440 | 69.8 K to 68.4 K (-1.99 %) |
| Mar 23 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 78.52 | 5,519 | 433,352 | 302,498 | 308 K to 302.5 K (-1.79 %) |
| Mar 23 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 78.52 | 1,513 | 118,801 | 62,620 | 64.1 K to 62.6 K (-2.36 %) |
| Mar 19 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 77.99 | 1,308 | 102,011 | 64,133 | 65.4 K to 64.1 K (-2.00 %) |
| Mar 19 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 77.99 | 1,308 | 102,011 | 64,133 | 65.4 K to 64.1 K (-2.00 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Guyer Charles Greg | EVP, Chief Technica ... | Option Exercise | A | 78.39 | 25,650 | 2,010,704 | 25,650 | |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Guyer Charles Greg | EVP, Chief Technica ... | Grant | A | 0.00 | 10,420 | 0 | 45,460 | 35 K to 45.5 K (+29.74 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | EVP, Chief Financia ... | Option Exercise | A | 78.39 | 24,890 | 1,951,127 | 24,890 | |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | EVP, Chief Financia ... | Payment of Exercise | F | 77.21 | 582 | 44,936 | 37,224 | 37.8 K to 37.2 K (-1.54 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | EVP, Chief Financia ... | Payment of Exercise | F | 78.39 | 994 | 77,920 | 37,806 | 38.8 K to 37.8 K (-2.56 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | EVP, Chief Financia ... | Grant | A | 0.00 | 10,110 | 0 | 38,800 | 28.7 K to 38.8 K (+35.24 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Option Exercise | A | 78.39 | 25,650 | 2,010,704 | 25,650 | |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Payment of Exercise | F | 77.21 | 1,252 | 96,667 | 69,831 | 71.1 K to 69.8 K (-1.76 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Payment of Exercise | F | 78.39 | 5,014 | 393,047 | 71,083 | 76.1 K to 71.1 K (-6.59 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 0.00 | 10,420 | 0 | 76,097 | 65.7 K to 76.1 K (+15.87 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | A | 78.39 | 37,710 | 2,956,087 | 37,710 | |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Payment of Exercise | F | 77.21 | 2,259 | 174,417 | 108,596 | 110.9 K to 108.6 K (-2.04 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Payment of Exercise | F | 78.39 | 7,460 | 584,789 | 110,855 | 118.3 K to 110.9 K (-6.31 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Grant | A | 0.00 | 15,320 | 0 | 118,315 | 103 K to 118.3 K (+14.87 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Option Exercise | A | 78.39 | 26,400 | 2,069,496 | 26,400 | |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 77.21 | 1,287 | 99,369 | 65,441 | 66.7 K to 65.4 K (-1.93 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 78.39 | 5,273 | 413,350 | 66,728 | 72 K to 66.7 K (-7.32 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Grant | A | 0.00 | 10,720 | 0 | 72,001 | 61.3 K to 72 K (+17.49 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 78.39 | 101,820 | 7,981,670 | 101,820 | |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 77.21 | 5,559 | 429,210 | 308,017 | 313.6 K to 308 K (-1.77 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 78.39 | 23,426 | 1,836,364 | 313,576 | 337 K to 313.6 K (-6.95 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 41,350 | 0 | 337,002 | 295.7 K to 337 K (+13.99 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Acosta Andrea | GVP, Chief Accounti ... | Option Exercise | A | 78.39 | 5,280 | 413,899 | 5,280 | |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Acosta Andrea | GVP, Chief Accounti ... | Payment of Exercise | F | 77.21 | 379 | 29,263 | 18,136 | 18.5 K to 18.1 K (-2.05 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Acosta Andrea | GVP, Chief Accounti ... | Payment of Exercise | F | 78.39 | 553 | 43,350 | 18,515 | 19.1 K to 18.5 K (-2.90 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | Acosta Andrea | GVP, Chief Accounti ... | Grant | A | 0.00 | 4,290 | 0 | 19,068 | 14.8 K to 19.1 K (+29.03 %) |
| Mar 15 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 7,000 | 185,430 | 78,513 | |
| Mar 15 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 7,000 | 185,430 | 85,513 | |
| Mar 15 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 77.10 | 7,000 | 539,700 | 295,652 | 302.7 K to 295.7 K (-2.31 %) |
| Mar 15 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 7,000 | 185,430 | 302,652 | 295.7 K to 302.7 K (+2.37 %) |
| Mar 15 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 77.68 | 7,000 | 543,760 | 295,652 | 302.7 K to 295.7 K (-2.31 %) |
| Mar 15 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 7,000 | 185,430 | 302,652 | 295.7 K to 302.7 K (+2.37 %) |
| Mar 15 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | L | 77.94 | 100 | 7,794 | 295,652 | 295.6 K to 295.7 K (+0.03 %) |